PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER

This publication has 31 references indexed in Scilit:

• TYPHOID VACCINES
  The Lancet, 1987
• Selective Primary Health Care: Strategies for Control of Disease in the Developing World. XX. Typhoid Fever
  Clinical Infectious Diseases, 1985
• Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever
  European Journal of Clinical Microbiology & Infectious Diseases, 1985
• FAILURES WITH ORAL TYPHOID VACCINE Ty 21a
  The Lancet, 1983
• Is there a genetic immune defect in families with meningococcal meningitis?
  Journal of Infection, 1981
• Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
  New England Journal of Medicine, 1977
• A SEVEN-YEAR FIELD TRIAL OF TWO TYPHOID VACCINES IN GUYANA
  The Lancet, 1967
• D‐Galaktosaminuronsäure (2‐Amino‐2‐desoxy‐D‐galakturonsäure) als Baustein des Vi‐Antigens
  European Journal of Inorganic Chemistry, 1959
• The pathogenic and immunogenic activities ofSalmonella typhiin relation to its antigenic constituents
  Epidemiology and Infection, 1951
• TYPING OF TYPHOID BACILLI WITH Vi BACTERIOPHAGE
  The Lancet, 1947